Betting big in China - but will it pay off for Pharma?

For 18 out of the last 20 centuries, China has stood as the world’s most innovative and largest economy - only to have been displaced in the last two. However, the tables are turning once more, as pharma companies bet big by shutting down sites in Europe and the USA and expanding their R&D operations in China, particularly in Shanghai and Beijing. A large proportion of the pharma industry believes pharmaceutical innovation will accelerate in the East and that local R&D will develop a more customized solution to these growing and increasingly important markets.